Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2383]

Enzalutamide plus androgen deprivation therapy prolongs survival in men with...

Prof Andrew Armstrong - Duke University, Durham, USA

Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-sensitive prostate cancer ( Prof Andrew Armstrong - Duke University, Durham, USA )

Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve...

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve efficacy in ovarian, fallopian, peritoneal cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

Drug combination shows promise in treatment-resistant advanced ovarian cancer

Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK

Drug combination shows promise in treatment-resistant advanced ovarian cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal...

Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer ( Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA )

Adding abiraterone acetate plus prednisolone to standard therapy lengthens...

Prof Nick James - The Institute of Cancer Research, London, UK

Adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metastatic high-risk prostate cancer ( Prof Nick James - The Institute of Cancer Research, London, UK )

Welcome to APCCC 2021

Prof Silke Gillessen and Prof Aurelius Omlin

Welcome to APCCC 2021 ( Prof Silke Gillessen and Prof Aurelius Omlin )

ESMO 2021 Roundup

Dr Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2021 Roundup ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

OncoAlert and ecancer - ESMO 2021 Day 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer - ESMO 2021 Day 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

New MM patients with high levels of circulating tumour cells distinguished by...

Dr Cathelijne Fokkema - Erasmus MC Cancer Institute, Rotterdam, Netherlands

New MM patients with high levels of circulating tumour cells distinguished by increased bone marrow plasma cell proliferation ( Dr Cathelijne Fokkema - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

Exceptional response to oral metronomic chemotherapy in a rare case of...

Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India

Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanoma ( Dr Akhil Kapoor - Tata Memorial Hospital, Mumbai, India )

PARP inhibitors in prostate cancer: Case based testing and clinical decisions

Dr Neal Shore and Prof Fred Saad

PARP inhibitors in prostate cancer: Case based testing and clinical decisions ( Dr Neal Shore and Prof Fred Saad )

Disparities in myeloma: Closing the gap

Prof Joseph Mikhael - Translational Genomics Research Institute, Pheonix, USA

Disparities in myeloma: Closing the gap ( Prof Joseph Mikhael - Translational Genomics Research Institute, Pheonix, USA )

More from ecancer